Predictors of severe cerebral ischemia in premature infants
https://doi.org/10.23946/2500-0764-2019-4-3-15-21
Abstract
Aim. To identify informative predictors of severe cerebral ischemia in preterm neonates.
Materials and Methods. Study sample consisted of 80 preterm infants with intrauterine hypoxia or perinatal asphyxia delivered on the 28th-34th week of gestation. Levels of matrix metalloproteinase-9 (MMP-9) and thiobarbituric acid reactive substances (TBARS) as well as activity of antioxidant enzymes superoxide dismutase, catalase, and glutathione peroxidase in cord blood plasma of premature infants were evaluated immediately after birth.
Results. As compared to other newborns, neonates with severe cerebral ischemia had higher levels of MMP-9 (MMP-9 > 305.6 ng/mL in 14.6% versus 69.7%, respectively) and TBARS in cord blood plasma.
Conclusion. MMP-9 and TBARS measured in cord blood plasma of preterm infants may be utilised in diagnostics of severe cerebral ischemia.
About the Authors
O. V. RemnevaRussian Federation
MD, DSc, Head of the Department of Obstetrics and Gynecology,
N. I. Fadeeva
Russian Federation
MD, DSc, Department of Obstetrics and Gynecology,
Barnaul
Yu. V. Korenovskiy
Russian Federation
MD, PhD, Head of the Department of General and Biological Chemistry and Clinical and Laboratory Diagnostics,
Barnaul
O. V. Kolyado
Russian Federation
MD, PhD Student, Department of Obstetrics and Gynecology,
40, Lenina Street, Barnaul, 656038
References
1. Kurinczuk JJ, White-Koning M, Badawi N. Epidemiology of neonatal encephalopathy and hypoxic-ischaemic encephalopathy. Early Hum Dev. 2010;86(6):329-338. DOI: 10.1016/j.earlhumdev.2010.05.010
2. Lawn JE, Cousens S, Zupan J; Lancet Neonatal Survival Steering Team. 4 million neonatal deaths: When? Where? Why? Lancet. 2005;365(9462):891-900. DOI: 10.1016/S0140-6736(05)71048-5
3. Marlow N, Budge H. Prevalence, causes, and outcome at 2 years of age of newborn encephalopathy. Arch Dis Child Fetal Neonatal Ed. 2005;(3):193-194. DOI: 10.1136/adc.2004.057059
4. Al-Macki N, Miller SP, Hall N, Shevell M. The spectrum of abnormal neurologic outcomes subsequent to term intrapartum asphyxia. Pediatr Neurol. 2009;41(6):399-405. DOI: 10.1016/j.pediatrneurol.2009.06.001
5. Brew N, Walker D, Wong FY. Cerebral vascular regulation and brain injury in preterm infants. Am J Physiol Regul Integr Comp Physiol. 2014;306(11):773-786. DOI: 10.1152/ ajpregu.00487.2013
6. Ballabh P. Intraventricular hemorrhage in premature infants: mechanism of disease. Pediatr Res. 2010;67(1):1-8. DOI: 10.1203/PDR.0b013e3181c1b176
7. Korenovsky YV, Elchaninova SA, Shabalina YV. Matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in perinatal nervous system lesions. Mat' i ditya v Kuzbasse. 2012;(2(49)):14-17. (In Russ.).
8. Cunningham L, Wetzel M, Rosenberg G. Multiple Roles for MMPs and TIMPs in Cerebral Ischemia. Glia. 2005;50(4):329- 339. DOI: 10.1002/glia.20169
9. Rosell A, Ortega-Aznar J, Alvarez-Sabín J, FernándezCadenas I, Ribó M, Molina CA, Lo EH, Montaner J. Increased brain expression of matrix metalloproteinase-9 after ischemic and hemorrhagic human stroke. Stroke. 2006;37(6):1399-1406. DOI: 10.1161/01.STR.0000223001.06264.af
10. Bednarek N, Svedin P, Garnotel R. Favrais G, Loron G, Schwendiman L, Hagberg H, Morville P, Mallard C, Gressens P. Increased MMP-9 and TIMP-1 in mouse neonatal brain and plasma and in human neonatal plasma after hypoxia-ischemia: a potential marker of neonatal encephalopathy. Pediatr Res. 2012;71(1):63-70. DOI: 10.1038/pr.2011.3
11. Yang S, Sharrocks A, Whitmarsh A. MAP kinase signalling cascades and transcriptional regulation. Gene. 2013;513(1):1- 13. DOI: 10.1016/j.gene.2012.10.033
Review
For citations:
Remneva O.V., Fadeeva N.I., Korenovskiy Yu.V., Kolyado O.V. Predictors of severe cerebral ischemia in premature infants. Fundamental and Clinical Medicine. 2019;4(3):15-21. (In Russ.) https://doi.org/10.23946/2500-0764-2019-4-3-15-21